OA
SWAV

Operose Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Operose Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-247
Closed -$49.2K – 752
2023
Q3 		$49.2K Buy
+247
New +$58.4K 0.02% 316

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Operose Advisors's SWAV Position: Q4 2023 in Review

Operose Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 247 shares — an estimated $49.2K sold.

Operose Advisors first reported a position in SWAV in Q3 2023 and held it in 1 quarter. The position peaked at $49.2K in Q3 2023. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Operose Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Operose Advisors sold 247 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $49.2K.
  • Operose Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Operose Advisors's Shockwave Medical, Inc. Common Stock position peaked at $49.2K in Q3 2023.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.